166 related articles for article (PubMed ID: 24778697)
1. Congenital muscular dystrophy type 1A with residual merosin expression.
Kim HJ; Choi YC; Park HJ; Lee YM; Kim HD; Lee JS; Kang HC
Korean J Pediatr; 2014 Mar; 57(3):149-52. PubMed ID: 24778697
[TBL] [Abstract][Full Text] [Related]
2. Merosin-deficient congenital muscular dystrophy type 1A.
Buteică E; Roşulescu E; Burada F; Stănoiu B; Zăvăleanu M
Rom J Morphol Embryol; 2008; 49(2):229-33. PubMed ID: 18516331
[TBL] [Abstract][Full Text] [Related]
3. Merosin-deficient congenital muscular dystrophy type 1A: A case report.
He Z; Luo X; Liang L; Li P; Li D; Zhe M
Exp Ther Med; 2013 Nov; 6(5):1233-1236. PubMed ID: 24223650
[TBL] [Abstract][Full Text] [Related]
4. Merosin-deficient congenital muscular dystrophy: A novel homozygous mutation in the laminin-2 gene.
Turner C; Mein R; Sharpe C; Love DR
J Clin Neurosci; 2015 Dec; 22(12):1983-5. PubMed ID: 26249246
[TBL] [Abstract][Full Text] [Related]
5. Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy.
Nguyen Q; Lim KRQ; Yokota T
Appl Clin Genet; 2019; 12():113-130. PubMed ID: 31308722
[TBL] [Abstract][Full Text] [Related]
6. Congenital Muscular Dystrophy Due to Merosin Deficiency: Report of a New Mutation.
Herrera Malpica WS; Ortiz-Corredor F; Sanchez Peñarete D; Muñetones Hernández PV
Cureus; 2023 Jun; 15(6):e39988. PubMed ID: 37416022
[TBL] [Abstract][Full Text] [Related]
7. Merosin-deficient congenital muscular dystrophy with mental retardation and cerebellar cysts, unlinked to the LAMA2, FCMD, MEB and CMD1B loci, in three Tunisian patients.
Triki C; Louhichi N; Méziou M; Choyakh F; Kéchaou MS; Jlidi R; Mhiri C; Fakhfakh F; Ayadi H
Neuromuscul Disord; 2003 Jan; 13(1):4-12. PubMed ID: 12467726
[TBL] [Abstract][Full Text] [Related]
8. Merosin-deficient congenital muscular dystrophy type 1a: detection of
Tran VK; Nguyen NL; Tran LNT; Le PT; Tran AH; Pham TLA; Lien NTK; Xuan NT; Thanh LT; Ta TV; Tran TH; Nguyen HH
Front Genet; 2023; 14():1183663. PubMed ID: 37388928
[No Abstract] [Full Text] [Related]
9. Congenital muscular dystrophy associated with merosin deficiency.
North KN; Specht LA; Sethi RK; Shapiro F; Beggs AH
J Child Neurol; 1996 Jul; 11(4):291-5. PubMed ID: 8807418
[TBL] [Abstract][Full Text] [Related]
10. Prenatal diagnosis in laminin alpha2 chain (merosin)-deficient congenital muscular dystrophy: a collective experience of five international centers.
Vainzof M; Richard P; Herrmann R; Jimenez-Mallebrera C; Talim B; Yamamoto LU; Ledeuil C; Mein R; Abbs S; Brockington M; Romero NB; Zatz M; Topaloglu H; Voit T; Sewry C; Muntoni F; Guicheney P; Tomé FM
Neuromuscul Disord; 2005 Oct; 15(9-10):588-94. PubMed ID: 16084089
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis of congenital muscular dystrophy and clinical significance of merosin expression].
Xiong H; Yao S; Yuan Y; Chang XZ; Wu Y; Bao XH; Zhang YH; Wu HS; Chen L; Qin J; Wu XR
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):918-23. PubMed ID: 17254461
[TBL] [Abstract][Full Text] [Related]
12. Merosin-negative congenital muscular dystrophy: Report of five cases.
Incecik F; Herguner OM; Ceylaner S; Altunbasak S
J Pediatr Neurosci; 2015; 10(4):346-9. PubMed ID: 26962340
[TBL] [Abstract][Full Text] [Related]
13. A cryptic intronic LAMA2 insertion in a boy with mild congenital muscular dystrophy type 1A.
Specht S; Duff J; Charlton R; Polvikoski T; Barresi R; Töpf A; Straub V
Neuromuscul Disord; 2021 Jul; 31(7):660-665. PubMed ID: 34074572
[TBL] [Abstract][Full Text] [Related]
14. Late onset muscular dystrophy with cerebral white matter changes due to partial merosin deficiency.
Tan E; Topaloglu H; Sewry C; Zorlu Y; Naom I; Erdem S; D'Alessandro M; Muntoni F; Dubowitz V
Neuromuscul Disord; 1997 Mar; 7(2):85-9. PubMed ID: 9131648
[TBL] [Abstract][Full Text] [Related]
15. A novel
Tran KT; Le VS; Vu CD; Nguyen LT
Biomed Rep; 2020 Feb; 12(2):46-50. PubMed ID: 31929873
[TBL] [Abstract][Full Text] [Related]
16. Muscle MRI findings in a one-year-old girl with merosin-deficient congenital muscular dystrophy type 1A due to LAMA2 mutation: A case report.
Liang Y; Li G; Chen S; He R; Zhou X; Chen Y; Xu X; Zhu R; Zhang C
Biomed Rep; 2017 Aug; 7(2):193-196. PubMed ID: 28804634
[TBL] [Abstract][Full Text] [Related]
17. Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy.
Rooney JE; Knapp JR; Hodges BL; Wuebbles RD; Burkin DJ
Am J Pathol; 2012 Apr; 180(4):1593-602. PubMed ID: 22322301
[TBL] [Abstract][Full Text] [Related]
18. Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations.
Geranmayeh F; Clement E; Feng LH; Sewry C; Pagan J; Mein R; Abbs S; Brueton L; Childs AM; Jungbluth H; De Goede CG; Lynch B; Lin JP; Chow G; Sousa Cd; O'Mahony O; Majumdar A; Straub V; Bushby K; Muntoni F
Neuromuscul Disord; 2010 Apr; 20(4):241-50. PubMed ID: 20207543
[TBL] [Abstract][Full Text] [Related]
19. Sequential neuroradiological and neurophysiological studies in a Japanese girl with merosin-deficient congenital muscular dystrophy.
Fujii Y; Sugiura C; Fukuda C; Maegaki Y; Ohno K
Brain Dev; 2011 Feb; 33(2):140-4. PubMed ID: 20303224
[TBL] [Abstract][Full Text] [Related]
20. Identification of a compound heterozygous missense mutation in LAMA2 gene from a patient with merosin-deficient congenital muscular dystrophy type 1A.
Khorrami A; Goleij P; Karamad V; Taheri E; Shadman B; Emami P; Jahangirzadeh G; Hajazimian S; Isazadeh A; Baradaran B; Heidari M
J Clin Lab Anal; 2021 Nov; 35(11):e23930. PubMed ID: 34528292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
